Aquinox Prices Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/12/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Canaccord Genuity Raises Price Target on Aquinox Pharma (AQXP) to $22 on Supporting Evidence for AQX-1125
September 11, 2015 9:24 AM EDTCanaccord Genuity reiterated a Buy rating on Aquinox Pharmaceutical (NASDAQ: AQXP), and raised the price target to $22.00 (from $10.00), on supporting evidence for AQX-1125, and ahead of FDA meetings. Aquinox will meet with FDA, on BPS/IC, for an end of P2 meeting in Nov. to finalize two Ph3's, the 1st of which should start by mid-2016.
Analyst... More
Aquinox Pharma (AQXP) 5.5M Offering Common Stock Prices at $15.50/Share
September 10, 2015 9:15 AM EDTAquinox Pharma (NASDAQ: AQXP) announced the pricing of an underwritten public offering of 5,500,000 shares of its common stock at a price to the public of $15.50 per share. In addition, Aquinox has granted the underwriters a 30-day option to purchase up to 825,000 additional... More
